ACAD Competitors
ACADIA Pharmaceuticals Inc.
$19.78
+$0.20(+1.02%)
50
Overall
75
Value
9
Tech
68
Quality
Market Cap
$3.37B
Volume
1.47M
52W Range
$19.59 - $30.96
Target Price
$32.15
ACAD competitors: VNDA, BMY, PFE, JNJ, LLY. ACADIA Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ACAD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals Inc. | $4.57 | $273.90M | $-3.02 | - | 37 |
| BMY Bristol-Myers Squibb Company | $59.42 | $121.70B | $6.95 | 3.18% | 55 |
| PFE Pfizer Inc. | $28.26 | $158.56B | $2.98 | 6.09% | 74 |
| JNJ Johnson & Johnson | $260.81 | $618.09B | $11.54 | 2.02% | 50 |
| LLY Eli Lilly and Company | $1179.27 | $1.10T | $36.66 | 0.57% | 62 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $19.78 | +1.0% | 1.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW